Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 2, 2014Journal of Clinical Oncology

Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study

View Full Paper
Ask AI
Bookmark
Share

Authors

JBJean-François BoileauJewish General HospitalBPBrigitte PoirierCentre hospitalier universitaire de QuébecMBMark BasikJewish General Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Boileau et al. (2014) studied this question.

synapsesocial.com/papers/69d83f2b5c3030ff03d19935https://doi.org/10.1200/jco.2014.55.7827
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer2013 · 1,604 citations
  2. 2Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial2006 · 1,690 citations
  3. 3Clinicopathologic Factors Associated With False-Negative Sentinel Lymph-Node Biopsy in Breast Cancer2005 · 101 citations
  4. 4Locoregional Radiotherapy in Patients With Breast Cancer Responding to Neoadjuvant Chemotherapy: A Paradigm for Treatment Individualization2013 · 49 citations
  5. 5Outcome After Pathologic Complete Eradication of Cytologically Proven Breast Cancer Axillary Node Metastases Following Primary Chemotherapy2005 · 429 citations